Related references
Note: Only part of the references are listed.Current and emerging treatment modalities for metastatic castration-resistant prostate cancer
Sergio Bracarda et al.
BJU INTERNATIONAL (2011)
Global Cancer Statistics
Ahmedin Jemal et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2011)
EAU Guidelines on Prostate Cancer. Part 1: Screening, Diagnosis, and Treatment of Clinically Localised Disease
Axel Heidenreich et al.
EUROPEAN UROLOGY (2011)
EAU Guidelines on Prostate Cancer. Part II: Treatment of Advanced, Relapsing, and Castration-Resistant Prostate Cancer
Nicolas Mottet et al.
EUROPEAN UROLOGY (2011)
Outcomes and predictive factors for biochemical relapse following primary androgen deprivation therapy in men with bone scan negative prostate cancer
S. Hori et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2011)
Prostate cancer incidence, stage at diagnosis, treatment and survival in ethnic groups in South-East England
Ruth H. Jack et al.
BJU INTERNATIONAL (2010)
Androgen receptor expression is associated with prostate cancer-specific survival in castrate patients with metastatic disease
Michael J. Donovan et al.
BJU INTERNATIONAL (2010)
Hierarchical clustering of immunohistochemical analysis of the activated ErbB/PI3K/Akt/NF-κB signalling pathway and prognostic significance in prostate cancer
I. H. Koumakpayi et al.
BRITISH JOURNAL OF CANCER (2010)
Prostate cancer genes associated with TMPRSS2-ERG gene fusion and prognostic of biochemical recurrence in multiple cohorts
B. G. Barwick et al.
BRITISH JOURNAL OF CANCER (2010)
Low Level Her2 Overexpression Is Associated with Rapid Tumor Cell Proliferation and Poor Prognosis in Prostate Cancer
Sarah Minner et al.
CLINICAL CANCER RESEARCH (2010)
EXPRESSION OF Bcl-2, p53, AND MDM2 IN LOCALIZED PROSTATE CANCER WITH RESPECT TO THE OUTCOME OF RADICAL RADIOTHERAPY DOSE ESCALATION
Roy Vergis et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2010)
Clinical Implications of TMPRSS2-ERG Gene Fusion Expression in Patients With Prostate Cancer Treated With Radical Prostatectomy
Jose Rubio-Briones et al.
JOURNAL OF UROLOGY (2010)
The EGFR Polymorphism rs884419 is Associated With Freedom From Recurrence in Patients With Resected Prostate Cancer
Carmen A. Perez et al.
JOURNAL OF UROLOGY (2010)
HER-2/neu Expression in Prostate Adenocarcinoma: A Systematic Review and Meta-Analysis
Ary Serpa Neto et al.
JOURNAL OF UROLOGY (2010)
Overexpression of C-MYC oncogene in prostate cancer predicts biochemical recurrence
D. Hawksworth et al.
PROSTATE CANCER AND PROSTATIC DISEASES (2010)
Expression of potential molecular markers in prostate cancer: Correlation with clinicopathological outcomes in patients undergoing radical prostatectomy
Hideaki Miyake et al.
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS (2010)
Prognostic value of microvessel density in prostate cancer: a tissue microarray study
Andreas Erbersdobler et al.
WORLD JOURNAL OF UROLOGY (2010)
Utility of tissue microarrays for profiling prognostic biomarkers in clinically localized prostate cancer: the expression of BCL-2, E-cadherin, Ki-67 and p53 as predictors of biochemical failure after radical prostatectomy with nested control for clinical and pathological risk factors
Joseph Nariculam et al.
ASIAN JOURNAL OF ANDROLOGY (2009)
Ki-67 and outcome in clinically localised prostate cancer: analysis of conservatively treated prostate cancer patients from the Trans-Atlantic Prostate Group study
D. M. Berney et al.
BRITISH JOURNAL OF CANCER (2009)
Proliferation of Immature Tumor Vessels Is a Novel Marker of Clinical Progression in Prostate Cancer
Karsten Gravdal et al.
CANCER RESEARCH (2009)
Overexpression of Prostate-Specific TMPRSS2(exon 0)-ERG Fusion Transcripts Corresponds with Favorable Prognosis of Prostate Cancer
Karin G. Hermans et al.
CLINICAL CANCER RESEARCH (2009)
Prognostic Value of Akt-1 in Human Prostate Cancer: A Computerized Quantitative Assessment with Quantum Dot Technology
Rile Li et al.
CLINICAL CANCER RESEARCH (2009)
The Importance of Protein Kinase A in Prostate Cancer: Relationship to Patient Outcome in Radiation Therapy Oncology Group Trial 92-02
Alan Pollack et al.
CLINICAL CANCER RESEARCH (2009)
Predictive Value of the Differential Expression of the Urokinase Plasminogen Activation Axis in Radical Prostatectomy Patients
Amit Gupta et al.
EUROPEAN UROLOGY (2009)
Tumour growth fraction measured by immunohistochemical staining of Ki67 is an independent prognostic factor in preoperative prostate biopsies with small-volume or low-grade prostate cancer
Tobias Zellweger et al.
INTERNATIONAL JOURNAL OF CANCER (2009)
Characterization of the Expression of Variant and Standard CD44 in Prostate Cancer Cells: Identification of the Possible Molecular Mechanism of CD44/MMP9 Complex Formation on the Cell Surface
B. Desai et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2009)
Endothelial NOS, estrogen receptor β, and HIFs cooperate in the activation of a prognostic transcriptional pattern in aggressive human prostate cancer
Simona Nanni et al.
JOURNAL OF CLINICAL INVESTIGATION (2009)
MDM2 and Ki-67 Predict for Distant Metastasis and Mortality in Men Treated With Radiotherapy and Androgen Deprivation for Prostate Cancer: RTOG 92-02
Li-Yan Khor et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Bcl2-938C/A Polymorphism Carries Increased Risk of Biochemical Recurrence After Radical Prostatectomy
Hiroshi Hirata et al.
JOURNAL OF UROLOGY (2009)
Personalized Prediction of Tumor Response and Cancer Progression on Prostate Needle Biopsy
Michael J. Donovan et al.
JOURNAL OF UROLOGY (2009)
Expression of urokinase-type plasminogen activator system in prostate cancer: Correlation with clinicopathological outcomes in patients undergoing radical prostatectomy
Masafumi Kumano et al.
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS (2009)
Genetic profile identification in clinically localized prostate carcinoma
Michele Gallucci et al.
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS (2009)
Human epidermal growth factor receptor type 2 protein expression in Chinese metastatic prostate cancer patients correlates with cancer specific survival and increases after exposure to hormonal therapy
Bo Dai et al.
ASIAN JOURNAL OF ANDROLOGY (2008)
Co-assessment of cytoplasmic and nuclear androgen receptor location in prostate specimens: potential implications for prostate cancer development and prognosis
Jean-Simon Diallo et al.
BJU INTERNATIONAL (2008)
Association of TMPRSS2-ERG gene fusion with clinical characteristics and outcomes: results from a population-based study of prostate cancer
Liesel M. FitzGerald et al.
BMC CANCER (2008)
Is PTEN loss associated with clinical outcome measures in human prostate cancer?
P. McCall et al.
BRITISH JOURNAL OF CANCER (2008)
Nine-gene molecular signature is not associated with prostate cancer death in a watchful waiting cohort
Lorelei A. Mucci et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2008)
Distinct Subcellular Expression Patterns of Neutral Endopeptidase (CD10) in Prostate Cancer Predict Diverging Clinical Courses in Surgically Treated Patients
Achim Fleischmann et al.
CLINICAL CANCER RESEARCH (2008)
Osteopontin and interleukin-8 expression is independently associated with prostate cancer recurrence
Daniel J. Caruso et al.
CLINICAL CANCER RESEARCH (2008)
TMPRSS2:ERG fusion identifies a subgroup of prostate cancers with a favorable prognosis
Outi R. Saramaki et al.
CLINICAL CANCER RESEARCH (2008)
Prognostic value of Her-2/neu and DNA index for progression, metastasis and prostate cancer-specific death in men with long-term follow-up after radical prostatectomy
Sumit Isharwal et al.
INTERNATIONAL JOURNAL OF CANCER (2008)
Protein kinase A RI-α predicts for prostate cancer outcome:: Analysis of radiation therapy oncology group trial 86-10
Li-Yan Khor et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2008)
Neuroendocrine differentiation in stage D2 prostate cancers
Naoto Kamiya et al.
INTERNATIONAL JOURNAL OF UROLOGY (2008)
Expression of p27(Kip1), cyclin D3 and Ki67 in BPH, prostate cancer and hormone-treated prostate cancer cells
David Nikoleishvili et al.
INTERNATIONAL UROLOGY AND NEPHROLOGY (2008)
Gene panel model predictive of outcome in men at high-risk of systemic progression and death from prostate cancer after radical retropubic prostatectomy
John C. Cheville et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Clinical significance of p53 alterations in surgically treated prostate cancers
Thorsten Schlomm et al.
MODERN PATHOLOGY (2008)
Absence of TMPRSS2:ERG fusions and PTEN losses in prostate cancer is associated with a favorable outcome
Maisa Yoshimoto et al.
MODERN PATHOLOGY (2008)
Zinc α2-glycoprotein:: A multidisciplinary protein
Md Imtaiyaz Hassan et al.
MOLECULAR CANCER RESEARCH (2008)
Intrinsic markers of tumour hypoxia and angiogenesis in localised prostate cancer and outcome of radical treatment: a retrospective analysis of two randomised radiotherapy trials and one surgical cohort study
Roy Vergis et al.
LANCET ONCOLOGY (2008)
A Tissue Biomarker Panel Predicting Systemic Progression after PSA Recurrence Post-Definitive Prostate Cancer Therapy
Tohru Nakagawa et al.
PLOS ONE (2008)
Elevated levels of HER-2/neu and androgen receptor in clinically localized prostate cancer identifies metastatic potential
Carmela Ricciardelli et al.
PROSTATE (2008)
Long-Term Assessment of Prostate Cancer Progression Free Survival: Evaluation of Pathological Parameters, Nuclear Shape and Molecular Biomarkers of Pathogenesis
Robert W. Veltri et al.
PROSTATE (2008)
Utility of bcl-2, p53, Ki-67, and caveolin-1 immunostaining in the prediction of biochemical failure after radical prostatectomy in a Japanese population
Takahiro Goto et al.
UROLOGY (2008)
Ki67 staining index and neuroendocrine differentiation aggravate adverse prognostic parameters in prostate cancer and are characterized by negligible inter-observer variability
Sven Gunia et al.
WORLD JOURNAL OF UROLOGY (2008)
Predictive value of PTEN and AR coexpression of sustained responsiveness to hormonal therapy in prostate cancer - A pilot study
Soha S. El Sheikh et al.
NEOPLASIA (2008)
Transcriptome analyses of benign and malignant prostate epithelial cells in formalin-fixed paraffin-embedded whole-mounted radical prostatectomy specimens
B. Furusato et al.
PROSTATE CANCER AND PROSTATIC DISEASES (2008)
EZH2, Ki-67 and MCM7 are prognostic markers in prostatectomy treated patients
Sari Laitinen et al.
INTERNATIONAL JOURNAL OF CANCER (2008)
Expression of the TMPRSS2:ERG fusion gene predicts cancer recurrence after surgery for localised prostate cancer
R. K. Nam et al.
BRITISH JOURNAL OF CANCER (2007)
B7-H3 and B7x are highly expressed in human prostate cancer and associated with disease spread and poor outcome
Xingxing Zang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Clinical significance of epidermal growth factor receptor protein overexpression and gene copy number gains in prostate cancer
Thorsten Schlomm et al.
CLINICAL CANCER RESEARCH (2007)
Prognostic significance of p53 and X-ray repair cross-complementing group 1 Polymorphisms on prostate-specific antigen recurrence in prostate cancer post-radical prostatectomy
Shu-Pin Huang et al.
CLINICAL CANCER RESEARCH (2007)
Prognostic value of abnormal p53 expression in locally advanced prostate cancer treated with androgen deprivation and radiotherapy: A study based on RTOG 9202
Mingxin Che et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2007)
COX-2 expression predicts prostate-cancer outcome: analysis of data from the RTOG 92-02 trial
Li-Yan Khor et al.
LANCET ONCOLOGY (2007)
Increased Akt and phosphorylated Akt expression are associated with malignant biological features of prostate cancer in Japanese men
Yousuke Shimizu et al.
BJU INTERNATIONAL (2007)
FISH analysis of 107 prostate cancers shows that PTEN genomic deletion is associated with poor clinical outcome
M. Yoshimoto et al.
BRITISH JOURNAL OF CANCER (2007)
B7-H3 ligand expression by prostate cancer: A novel marker of prognosis and potential target for therapy
Timothy J. Roth et al.
CANCER RESEARCH (2007)
Prognostic value of p16 in locally advanced prostate cancer: A study based on Radiation Therapy Oncology Group protocol 9202
Arnab Chakravarti et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Association of cysteine-rich secretory protein 3 and β-microseminoprotein with outcome after radical prostatectomy
Anders S. Bjartell et al.
CLINICAL CANCER RESEARCH (2007)
Determining risk of biochemical recurrence in prostate cancer by immunohistochemical detection of PTEN expression end Akt activation
Roble Bedolla et al.
CLINICAL CANCER RESEARCH (2007)
Improved prediction of prostate cancer recurrence through systems pathology
Carlos Cordon-Cardo et al.
JOURNAL OF CLINICAL INVESTIGATION (2007)
Bcl-2 and Bax expression predict prostate cancer outcome in men treated with androgen deprivation and radiotherapy on Radiation Therapy Oncology Group protocol 92-02
Li Yan Khor et al.
CLINICAL CANCER RESEARCH (2007)
Caveolin-1 overexpression is associated with aggressive prostate cancer recurrence
Jose A. Karam et al.
PROSTATE (2007)
A variant TMPRSS2 isoform and ERG fusion product in prostate cancer with implications for molecular diagnosis
Jacques Lapointe et al.
MODERN PATHOLOGY (2007)
Prognostic significance of proliferation activity and neuroendocrine differentiation to predict treatment failure after radical prostatectomy
Matthias May et al.
SCANDINAVIAN JOURNAL OF UROLOGY AND NEPHROLOGY (2007)
Loss of neutral endopeptidase and activation of protein kinase B (Akt) is associated with prostate cancer progression
Iman Osman et al.
CANCER (2006)
Zinc-alpha2-glycoprotein expression as a predictor of metastatic prostate cancer following radical prostatectomy
Susan M. Henshall et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2006)
CD44 and PTGS2 Methylation are Independent Prognostic Markers for Biochemical Recurrence Among Prostate Cancer Patients with Clinically Localized Disease
Karen Woodson et al.
EPIGENETICS (2006)
E-cadherin protein expression predicts prostate cancer salvage radiotherapy outcomes
Michael E. Ray et al.
JOURNAL OF UROLOGY (2006)
Intensity of androgen and epidermal growth factor receptor immunoreactivity in samples of radical prostatectomy as prognostic indicator:: Correlation with clinical data of long-term observations
Wolfgang Schaefer et al.
JOURNAL OF UROLOGY (2006)
Expression and localisation of Akt-1, Akt-2 and Akt-3 correlate with clinical outcome of prostate cancer patients
C. Le Page et al.
BRITISH JOURNAL OF CANCER (2006)
Radical prostatectomy as primary treatment modality for locally advanced prostate cancer: A prospective analysis
Ryan K. Berglund et al.
UROLOGY (2006)
Androgen-deprivation therapy as primary treatment for localized prostate cancer - Data from cancer of the prostate strategic urologic research endeavor (CaPSURE)
J Kawakami et al.
CANCER (2006)
Impact of patient age at treatment on outcome following radical retropubic prostatectomy for prostate cancer
SA Siddiqui et al.
JOURNAL OF UROLOGY (2006)
Biological correlates of p27 compartmental expression in prostate cancer
R Li et al.
JOURNAL OF UROLOGY (2006)
The role of HER1-HER4 and EGFRvIII in hormone-refractory prostate cancer
J Edwards et al.
CLINICAL CANCER RESEARCH (2006)
Expression of bFGF/FGFR-1 and vascular proliferation related to clinicopathologic features and tumor progress in localized prostate cancer
K Gravdal et al.
VIRCHOWS ARCHIV (2006)
Activation of nuclear factor-κB in human prostate carcinogenesis and association to biochemical relapse
J Domingo-Domenech et al.
BRITISH JOURNAL OF CANCER (2005)
Immunohistochemical expression of Ki-67 antigen, Cox-2 and Bax/Bcl-2 in prostate cancer;: Prognostic value in biopsies and radical prostatectomy specimens
J Rubio et al.
EUROPEAN UROLOGY (2005)
Androgen receptor, Ki67, and p53 expression in radical prostatectomy specimens predict treatment failure in Japanese population
T Inoue et al.
UROLOGY (2005)
Increased intratumoral expression of prostate secretory protein of 94 amino acids predicts for worse disease recurrence and progression after radical prostatectomy in patients with prostate cancer
AR Girvan et al.
UROLOGY (2005)
Combined c-Myc and caveolin-1 expression in human prostate carcinoma predicts prostate carcinoma progression
G Yang et al.
CANCER (2005)
Expression of biomarkers modulating prostate cancer progression: implications in the treatment of the disease
G Di Lorenzo et al.
PROSTATE CANCER AND PROSTATIC DISEASES (2005)
Is tumor vascularity in prostate core biopsies a predictor of PSA recurrence after radical prostatectomy?
A Khatami et al.
ACTA ONCOLOGICA (2005)
p53 and bcl-2 immunohistochemistry in preoperative biopsies as predictors of biochemical recurrence after radical prostatectomy
J.D. Oxley et al.
BJU INTERNATIONAL (2004)
Expression of nuclear factor-κB and IκBα proteins in prostatic adenocarcinomas:: Correlation of nuclear factor-κB immunoreactivity with disease recurrence
JS Ross et al.
CLINICAL CANCER RESEARCH (2004)
Expression of the epidermal growth factor receptor family in prostate carcinoma before and during androgen-independence
E Hernes et al.
BRITISH JOURNAL OF CANCER (2004)
Expression of p21 cell cycle protein is an independent predictor of response to salvage radiotherapy after radical prostatectomy
J Rigaud et al.
PROSTATE (2004)
Pattern of proliferative index (Ki-67) after anti-androgen manipulation reflects the ability of irradiation to control prostate cancer
BL Hintz et al.
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS (2004)
Gene expression profiling identifies clinically relevant subtypes of prostate cancer
J Lapointe et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Nuclear factor-κB nuclear localization is predictive of biochemical recurrence in patients with positive margin prostate cancer
V Fradet et al.
CLINICAL CANCER RESEARCH (2004)
High level of androgen receptor is associated with aggressive clinicopathologic features and decreased biochemical recurrence-free survival in prostate - Cancer patients treated with radical prostatectomy
R Li et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2004)
Neutral endopeptidase protein expression and prognosis in localized prostate cancer
I Osman et al.
CLINICAL CANCER RESEARCH (2004)
Ki-67 staining index predicts distant metastasis and survival in locally advanced prostate cancer treated with radiotherapy: An analysis of patients in radiation therapy oncology group protocol 86-10
RL Li et al.
CLINICAL CANCER RESEARCH (2004)
Ki-67 staining is a strong predictor of distant metastasis and mortality for men with prostate cancer treated with radiotherapy plus androgen deprivation: Radiation Therapy Oncology Group trial 92-02
A Pollack et al.
JOURNAL OF CLINICAL ONCOLOGY (2004)
Comparison of the prognostic potential of hyaluronic acid, hyaluronidase (HYAL-1), CD44v6 and microvessel density for prostate cancer
S Ekici et al.
INTERNATIONAL JOURNAL OF CANCER (2004)
High levels of phosphorylated form of Akt-1 in prostate cancer and non-neoplastic prostate tissues are strong predictors of biochemical recurrence
G Ayala et al.
CLINICAL CANCER RESEARCH (2004)
Loss of p16 expression is of prognostic significance in locally advanced prostate cancer: An analysis from the Radiation Therapy Oncology Group protocol 86-10
A Chakravarti et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
The prognostic value of p53 and DNA ploidy following radical prostatectomy
C Deliveliotis et al.
WORLD JOURNAL OF UROLOGY (2003)
The role of p53, bcl-2 and E-cadherin expression in predicting biochemical relapse for organ confined prostate cancer in Taiwan
TT Wu et al.
JOURNAL OF UROLOGY (2003)
Multiplex biomarker approach for determining risk of prostate-specific antigen-defined recurrence of prostate cancer
DR Rhodes et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2003)
Bcl-2 is significantly overexpressed in localized radio-recurrent prostate carcinoma, compared with localized radio-naive prostate carcinoma
CJ Rosser et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2003)
Molecular markers of outcome after radiotherapy in patients with prostate carcinoma - Ki-67, bcl-2, bax, and bcl-x
A Pollack et al.
CANCER (2003)
Prostate cancer DNA ploidy and response to salvage hormone therapy after radiotherapy with or without short-term total androgen blockade: An analysis of RTOG 8610
A Pollack et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
Preoperative p27 status is an independent predictor of prostate specific antigen failure following radical prostatectomy
SJ Freedland et al.
JOURNAL OF UROLOGY (2003)
Caveolin-1 expression is a predictor of recurrence-free survival in pT2N0 prostate carcinoma diagnosed in Japanese patients
T Satoh et al.
CANCER (2003)
Prognostic significance of matrix metalloproteinase 2 and tissue inhibitor of metalloproteinase 2 expression in prostate cancer
JS Ross et al.
MODERN PATHOLOGY (2003)
The polycomb group protein EZH2 is involved in progression of prostate cancer
S Varambally et al.
NATURE (2002)
The role of p53 in radiation therapy outcomes for favorable-to-intermediate-risk prostate cancer
MA Ritter et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2002)
Independent prognostic significance of Her-2 oncoprotein expression in pNO prostate cancer undergoing curative radiotherapy
A Fosså et al.
INTERNATIONAL JOURNAL OF CANCER (2002)
Prognostic factors in localised prostate cancer with emphasis on the application of molecular techniques
PCMS Verhagen et al.
EUROPEAN UROLOGY (2002)
Perineural invasion and MIB-1 positivity in addition to gleason score are significant preoperative predictors of progression after radical retropubic prostatectomy for prostate cancer
TJ Sebo et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2002)
Aneusomy of chromosomes 7, 8, and 17 and amplification of HER-2/neu and epidermal growth factor receptor in Gleason score 7 prostate carcinoma:: A differential fluorescent in situ hybridization study of Gleason pattern 3 and 4 using tissue microarray
M Skacel et al.
HUMAN PATHOLOGY (2001)
Relationship of p21WAF-1 protein expression with prognosis in advanced prostate cancer treated by androgen ablation
EA Omar et al.
PROSTATE (2001)
Abnormal E-cadherin expression and prostate cell blood dissemination as markers of biological recurrence in cancer
S Loric et al.
EUROPEAN JOURNAL OF CANCER (2001)
Use of Gleason score, prostate specific antigen, seminal vesicle and margin status to predict biochemical failure after radical prostatectomy
ML Blute et al.
JOURNAL OF UROLOGY (2001)
Her-2-neu expression and progression toward androgen independence in human prostate cancer
S Signoretti et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2000)
Prognostic value of cell cycle proteins p27kip1 and MIB-1, and the cell adhesion protein CD44s in surgically treated patients with prostate cancer
AN Vis et al.
JOURNAL OF UROLOGY (2000)
Preoperative prostate needle biopsy p27 correlates with subsequent radical prostatectomy p27, gleason grade and pathological stage
GV Thomas et al.
JOURNAL OF UROLOGY (2000)
Prognostic value of CD44 standard, variant isoforms 3 and 6 and α-catenin expression in local prostate cancer treated by radical prostatectomy
S Aaltomaa et al.
EUROPEAN UROLOGY (2000)
Outcome prediction with p53 immunostaining after radical prostatectomy in patients with locally advanced prostate cancer
BC Leibovich et al.
JOURNAL OF UROLOGY (2000)
Microvessel density, p53, retinoblastoma, and chromogranin a immunohistochemistry as predictors of disease-specific survival following radical prostatectomy for carcinoma of the prostate
T Krupski et al.
UROLOGY (2000)
Microvessel density as a predictor of PSA recurrence after radical prostatectomy - A comparison of CD34 and CD31
A de la Taille et al.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2000)
Prognostic significance of Ki-67 expression in advanced prostate cancers in relation to disease progression after androgen ablation
H Matsuura et al.
EUROPEAN UROLOGY (2000)
Share Paper
